Skip to content

PTHS PTHS Common Stock

Common Stock at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$51.73M+0.7%
Scilex Holding Company logo
Scilex Holding CompanySCLX
$1K0.0%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$6K+20.0%
Opko Health logo
Opko HealthOPK
$7.85M+11.9%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$1K0.0%
HRO
HarrowHROW
50M0.0%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+75.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's common stock?
PTHS (PTHS) reported common stock of 200M in Q1 2026.
How has PTHS's common stock changed year-over-year?
PTHS's common stock increased by 32206019.2% year-over-year, from 621 to 200M.
What is the long-term trend for PTHS's common stock?
Over 3 years (2022 to 2025), PTHS's common stock has grown at a 26.0% compound annual growth rate (CAGR), from 100M to 200M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).